Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?

Antimicrobial blue light (aBL) treatment is considered low risk for the development of bacterial resistance and tolerance due to its multitarget mode of action. The aim of the current study was to demonstrate whether tolerance development occurs in Gram-negative bacteria. We evaluated the potential...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Aleksandra Rapacka-Zdonczyk, Agata Wozniak, Beata Kruszewska, Krzysztof Waleron, Mariusz Grinholc
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/277b9fb2658145eba85b9794167e0213
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!